Anti-HBc quantitative detection method and uses thereof in monitoring and controlling disease progression of chronic hepatitis B patient and in predicting therapeutic effect
Disclosed in the present invention are an antibodies against hepatitis B core protein (Anti-HBc) quantitative detection method and the uses thereof in monitoring and controlling disease progression of a chronic hepatitis B patient and in predicting therapeutic effect. Anti-HBc are quantitatively detected, so that disease progression of a chronic hepatitis B patient is monitored and controlled, and the therapeutic effect on a chronic hepatitis B patient under anti-hepatitis B virus (HBV) treatment (especially, under treatment based on interferon and under treatment through anti-HBV medicine based on nucleoside or nucleotide analogues) is effectively predicted, thereby guiding the patient to reasonably select medicine.
